Grants and Contracts Details
Description
Scavenger receptor BI (SR-BI) is an HDL receptor that regulates HDL cholesterol
levels by mediating the delivery of HDL cholesterol esters to the liver. We recently
report a novel and potentially clinically important function of SR-BI in protection against
LPS-induced death. LPS challenge resulted in 90% fatality of SR-BI null mice, whereas
all the wild type littermates survived. More importantly, using a cecum ligation and
puncture (CLP) septic model, we demonstrate that CLP treatment induced 100% fatality
of SR-BI null mice whereas only 28.5% fatality of wild type littermates. Our findings
indicate that SR-BI is critical for survival during sepsis in mice. We hypothesize that SRBI
prevents LPS-induced death by facilitating LPS clearance and suppressing
inflammatory reactions. Understanding the mechanism whereby SR-BI prevents LPSinduced
death will elucidate a novel mechanism for survival during sepsis and may
reveal a strategy for intervention of sepsis.
Status | Finished |
---|---|
Effective start/end date | 9/30/09 → 8/31/12 |
Funding
- National Institute of General Medical Sciences: $225,227.00
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.